Depression in Multiple Sclerosis

Depression in Multiple Sclerosis

Up next

Treating Hearing Loss With Hearing Aids for the Prevention of Cognitive Decline and Dementia

Dr. Greg Cooper and Dr. Kerry Sheets discuss how hearing aid use affects cognition and the risk of dementia in older adults with hearing impairment. Show citations: Cribb L, Moreno-Betancur M, Pase MP, et al. Treating Hearing Loss With Hearing Aids for the Prevention of Cognitive ...  Show more

Migraine Clinical Trials from 2025

Dr. Jessica Ailani and Dr. Richard Lipton discuss future advancements in headache medicine. Show transcript: Dr. Jessica Ailani: Hello and welcome to the Neurology Minute. I'm Jessica Ilani from Georgetown Headache Center in Washington, DC. In the neurology podcast with Richard L ...  Show more

Recommended Episodes

Multiple Sclerosis and Family Planning
Neurology® Podcast

Dr. Shuvro Roy talks with Dr. Riley Bove about managing patients with multiple sclerosis as they navigate family planning and pregnancy. Read the related article in Neurology: Clinical Practice. Disclosures can be found at Neurology.org. 

MS in the Black Community
The ECTRIMS Podcast

With the growing push towards taking a more personalised approach to the treatment and management of multiple sclerosis, it is important to understand the unique issues – both socially and clinically – that may arise among people of different ethnicities. In this episode, Natalie ...  Show more

Winning Strategies in Multiple Sclerosis Treatment: Don't Underestimate the Disease
MS Living Well: Key Info from Multiple Sclerosis Experts

Treatment approaches to multiple sclerosis continue to change. Over the past quarter of a century, MS went from an untreatable disease to a disease responsive to a broad array of oral, intravenous and self-injected medications. Greater long-term disease control is now possible fo ...  Show more

Multiple Sclerosis, Rituximab, Hypogammaglobulinemia and Risk of Infections
Neurology® Podcast

Dr. Shuvro Roy talks with Dr. Annette Langer-Gould about the effective dose of rituximab and other B-cell depleting therapies in patients with multiple sclerosis, as well as important comorbidities to prevent infection risks. Read the related article in Neurology: Neuroimmunology ...  Show more